BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30445275)

  • 1. Effects of time-varying changes in tobacco and alcohol use on depressive symptoms following pharmaco-behavioral treatment for smoking and heavy drinking.
    Lechner WV; Sidhu NK; Cioe PA; Kahler CW
    Drug Alcohol Depend; 2019 Jan; 194():173-177. PubMed ID: 30445275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment.
    Kahler CW; Spillane NS; Busch AM; Leventhal AM
    Nicotine Tob Res; 2011 Feb; 13(2):146-50. PubMed ID: 21106663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of Alcohol Consumption and Successful Smoking Cessation.
    Lynch KL; Twesten JE; Stern A; Augustson EM
    Nicotine Tob Res; 2019 Jul; 21(8):1058-1064. PubMed ID: 29986105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Association Between Smoking Abstinence and Depression Severity in Those With Baseline Current, Past, and No History of Major Depressive Episode in an International Online Tobacco Cessation Study.
    Liu NH; Wu C; Pérez-Stable EJ; Muñoz RF
    Nicotine Tob Res; 2021 Jan; 23(2):267-275. PubMed ID: 32149344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interaction of Depressive Symptoms and Hazardous Drinking in Relation to Tobacco Craving Among Treatment Seeking Depressed Smokers: Sex Differences.
    Rodríguez-Cano R; López-Durán A; Paulus DJ; Martínez-Vispo C; Fernández Del Río E; Becoña E; Zvolensky MJ
    J Addict Med; 2018; 12(2):119-126. PubMed ID: 29219856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
    Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms.
    MacPherson L; Tull MT; Matusiewicz AK; Rodman S; Strong DR; Kahler CW; Hopko DR; Zvolensky MJ; Brown RA; Lejuez CW
    J Consult Clin Psychol; 2010 Feb; 78(1):55-61. PubMed ID: 20099950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of depressive symptoms on alcohol and cigarette consumption following treatment for alcohol and nicotine dependence.
    Kodl MM; Fu SS; Willenbring ML; Gravely A; Nelson DB; Joseph AM
    Alcohol Clin Exp Res; 2008 Jan; 32(1):92-9. PubMed ID: 18076750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized Treatment for Tobacco Dependence in Addictions Treatment Settings: The Role of Current Depressive Symptoms on Outcomes at 3 and 6 Months.
    Zawertailo LA; Baliunas D; Ivanova A; Selby PL
    Nicotine Tob Res; 2015 Aug; 17(8):937-45. PubMed ID: 26180218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between changes in alternative reinforcers and short-term smoking cessation.
    Goelz PM; Audrain-McGovern JE; Hitsman B; Leone FT; Veluz-Wilkins A; Jepson C; Wileyto EP; D'Avanzo PA; Rivera JG; Schnoll RA
    Drug Alcohol Depend; 2014 May; 138():67-74. PubMed ID: 24598122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.
    Zuo Y; Rabinovich NE; Gilbert DG
    Psychopharmacology (Berl); 2017 Mar; 234(5):761-771. PubMed ID: 28028602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.
    Cather C; Hoeppner S; Pachas G; Pratt S; Achtyes E; Cieslak KM; Evins AE
    J Dual Diagn; 2017; 13(3):168-178. PubMed ID: 28414583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms.
    Tidey JW; Pacek LR; Koopmeiners JS; Vandrey R; Nardone N; Drobes DJ; Benowitz NL; Dermody SS; Lemieux A; Denlinger RL; Cassidy R; al'Absi M; Hatsukami DK; Donny EC
    Nicotine Tob Res; 2017 Jan; 19(1):59-67. PubMed ID: 27613885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Time-Varying Relations Between Risk Factors and Smoking Before and After a Quit Attempt.
    Koslovsky MD; Hébert ET; Swartz MD; Chan W; Leon-Novelo L; Wilkinson AV; Kendzor DE; Businelle MS
    Nicotine Tob Res; 2018 Sep; 20(10):1231-1236. PubMed ID: 29059413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol use and initial smoking lapses among heavy drinkers in smoking cessation treatment.
    Kahler CW; Spillane NS; Metrik J
    Nicotine Tob Res; 2010 Jul; 12(7):781-5. PubMed ID: 20507898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control Study.
    Cooper J; Borland R; McKee SA; Yong HH; Dugué PA
    Addiction; 2016 Aug; 111(8):1438-47. PubMed ID: 26888199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence.
    Cooperman NA; Lu SE; Richter KP; Bernstein SL; Williams JM
    Nicotine Tob Res; 2018 Aug; 20(9):1152-1156. PubMed ID: 29059389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.
    Fridberg DJ; Cao D; Grant JE; King AC
    Alcohol Clin Exp Res; 2014 Oct; 38(10):2622-9. PubMed ID: 25335648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioral treatment with behavioral activation for smokers with depressive symptomatology: study protocol of a randomized controlled trial.
    Becoña E; Martínez-Vispo C; Senra C; López-Durán A; Rodríguez-Cano R; Fernández Del Río E
    BMC Psychiatry; 2017 Apr; 17(1):134. PubMed ID: 28390417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.